THERAPEUTIC AGENTS FOR MUSCULAR DYSTROPHY
    3.
    发明申请
    THERAPEUTIC AGENTS FOR MUSCULAR DYSTROPHY 审中-公开
    用于肌肉晶状体的治疗剂

    公开(公告)号:US20130302272A1

    公开(公告)日:2013-11-14

    申请号:US13988255

    申请日:2011-11-17

    IPC分类号: A61K38/19

    CPC分类号: A61K38/193

    摘要: The present invention provides therapeutic agents for diseases associated with skeletal muscle degeneration comprising a granulocyte colony-stimulating factor (G-CSF) as an active ingredient. The therapeutic agents of the present invention are especially effective as therapeutic agents for muscular dystrophy.

    摘要翻译: 本发明提供与骨骼肌变性相关的疾病的治疗剂,其包含粒细胞集落刺激因子(G-CSF)作为活性成分。 本发明的治疗剂作为肌营养不良症的治疗剂是特别有效的。

    MUSCLE REPAIR PROMOTER
    7.
    发明申请
    MUSCLE REPAIR PROMOTER 审中-公开
    肌肉修复促进器

    公开(公告)号:US20120114594A1

    公开(公告)日:2012-05-10

    申请号:US13319570

    申请日:2009-11-16

    IPC分类号: A61K38/19 A61P21/00

    CPC分类号: A61K38/193 Y10S930/145

    摘要: The present invention relates to muscle repair promoters for topical application that contain a colony-stimulating factor (CSF) as an active ingredient. The muscle repair promoters of the present invention exhibit their effect at low doses, particularly when they are administered intramuscularly.

    摘要翻译: 本发明涉及含有作为活性成分的集落刺激因子(CSF)的局部应用的肌肉修复促进剂。 本发明的肌肉修复促进剂在低剂量下表现出其作用,特别是当肌肉内给药时。

    Methods for inducing cell death in pluripotent stem cells and differentiated cells other than cardiac myocytes
    10.
    发明授权
    Methods for inducing cell death in pluripotent stem cells and differentiated cells other than cardiac myocytes 有权
    在多能干细胞和心肌细胞以外的分化细胞中诱导细胞死亡的方法

    公开(公告)号:US08735152B2

    公开(公告)日:2014-05-27

    申请号:US13260224

    申请日:2010-03-29

    IPC分类号: C12N5/00 C12N5/02

    摘要: The present invention has as its object developing a method that does not involve genomic modification and which yet is capable of inducing cell death in pluripotent stem cells such as embryonic stem cells and induced pluripotent stem cells, as well as in differentiated cells other than cardiomyocytes derived from pluripotent stem cells, but not in cardiomyocytes. It has been revealed that by establishing a method capable of inducing cell death in cells other than cardiomyocytes in a very efficient manner by adding a substance having no recognized inherent toxicity or cell death inducing action to the culture conditions for pluripotent stem cells and non-cardiomyocytes, the stated problem can be solved without relying upon genomic modification.

    摘要翻译: 本发明的目的是开发一种不涉及基因组修饰并且能够在多能干细胞如胚胎干细胞和诱导的多能干细胞以及除了心肌细胞以外的分化细胞中诱导细胞死亡的方法 来自多能干细胞,但不在心肌细胞中。 已经揭示出,通过向多能干细胞和非心肌细胞的培养条件中加入不具有公认的固有毒性或细胞死亡诱导作用的物质,通过建立能够以非常有效的方式在除心肌细胞之外的细胞中诱导细胞死亡的方法 所述问题可以解决而不依赖于基因组修饰。